| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1081/CNV-120001185 |
| P698 | PubMed publication ID | 12025235 |
| P2093 | author name string | Jeffrey S Miller | |
| P2860 | cites work | NKp44, a triggering receptor involved in tumor cell lysis by activated human natural killer cells, is a novel member of the immunoglobulin superfamily | Q22008826 |
| Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA | Q22010440 | ||
| An activating immunoreceptor complex formed by NKG2D and DAP10 | Q22010441 | ||
| DNA sequence analysis of NKG2, a family of related cDNA clones encoding type II integral membrane proteins on human natural killer cells | Q24295237 | ||
| A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules | Q24309285 | ||
| A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells | Q24310017 | ||
| Molecular cloning of NKp46: a novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicity | Q24310824 | ||
| Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells | Q24314176 | ||
| Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells | Q24315619 | ||
| Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains | Q24317666 | ||
| A multigene family on human chromosome 12 encodes natural killer-cell lectins | Q24321497 | ||
| A novel inhibitory receptor (ILT3) expressed on monocytes, macrophages, and dendritic cells involved in antigen processing | Q24321561 | ||
| Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells | Q24671834 | ||
| Target lysis by human lak cells is critically dependent upon target binding properties, but LFA-1, LFA-3 AND ICAM-1 are not the major adhesion ligands on targets | Q41698359 | ||
| Thymocyte selection is regulated by the helix-loop-helix inhibitor protein, Id3. | Q41717817 | ||
| The CD2-subset of the Ig superfamily of cell surface molecules: receptor-ligand pairs expressed by NK cells and other immune cells | Q41730102 | ||
| Constitutive expression of high affinity interleukin 2 receptors on human CD16-natural killer cells in vivo | Q41900284 | ||
| P58 molecules as putative receptors for major histocompatibility complex (MHC) class I molecules in human natural killer (NK) cells. Anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specificitie | Q42045430 | ||
| Identity of Leu-19 (CD56) leukocyte differentiation antigen and neural cell adhesion molecule | Q42115568 | ||
| Response of resting human peripheral blood natural killer cells to interleukin 2. | Q42153962 | ||
| Importance of immunoglobulin isotype in human antibody-dependent, cell-mediated cytotoxicity directed by murine monoclonal antibodies | Q42937245 | ||
| Identification of four subsets of human CD3-CD16+ natural killer (NK) cells by the expression of clonally distributed functional surface molecules: correlation between subset assignment of NK clones and ability to mediate specific alloantigen recogn | Q42938918 | ||
| Inhibition of T cell and promotion of natural killer cell development by the dominant negative helix loop helix factor Id3. | Q42951830 | ||
| Increased release of interleukin-1 and tumour necrosis factor by interleukin-2-induced lymphokine-activated killer cells in the presence of cisplatin and FK-565 | Q44081761 | ||
| MHC class I alloantigen specificity of Ly-49+ IL-2-activated natural killer cells | Q46115186 | ||
| NK and LAK activities from human marrow progenitors. I. The effects of interleukin-2 and interleukin-1. | Q52242255 | ||
| Population dynamics of human activated natural killer cells in culture. | Q52378632 | ||
| Differential responses to interleukin 2 define functionally distinct subsets of human natural killer cells | Q58415220 | ||
| Differential expression of CD8α and CD8β associated with MHC-restricted and non-MHC-restricted cytolytic effector cells | Q58415226 | ||
| An HMG-box-containing T-cell factor required for thymocyte differentiation. | Q59058515 | ||
| Requirement for IRF-1 in the microenvironment supporting development of natural killer cells | Q59098134 | ||
| Pathogen-specific loss of host resistance in mice lacking the IFN-gamma-inducible gene IGTP | Q24679086 | ||
| Structure of CD94 reveals a novel C-type lectin fold: implications for the NK cell-associated CD94/NKG2 receptors | Q27639773 | ||
| Ikaros, an early lymphoid-specific transcription factor and a putative mediator for T cell commitment | Q28202932 | ||
| LAIR-1, a novel inhibitory receptor expressed on human mononuclear leukocytes | Q28248040 | ||
| In search of the 'missing self': MHC molecules and NK cell recognition | Q28250846 | ||
| Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors | Q28259065 | ||
| Human diversity in killer cell inhibitory receptor genes | Q28259075 | ||
| HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C | Q28263511 | ||
| Association of DAP12 with activating CD94/NKG2C NK cell receptors | Q28275848 | ||
| Interleukin 12 induces tyrosine phosphorylation and activation of STAT4 in human lymphocytes | Q28295404 | ||
| Functional association of CD7 with phosphatidylinositol 3-kinase: interaction via a YEDM motif | Q28296735 | ||
| The Ikaros gene is required for the development of all lymphoid lineages | Q28594316 | ||
| Biology of natural killer cells | Q29619728 | ||
| Production of granulocyte/macrophage-colony-stimulating factor by human natural killer cells. Modulation by the p75 subunit of the interleukin 2 receptor and by the CD2 receptor | Q34225129 | ||
| The c-kit ligand suppresses apoptosis of human natural killer cells through the upregulation of bcl-2. | Q35647500 | ||
| Binding properties of a cell adhesion molecule from neural tissue | Q36279067 | ||
| Functional consequences of interleukin 2 receptor expression on resting human lymphocytes. Identification of a novel natural killer cell subset with high affinity receptors | Q36351101 | ||
| Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor | Q36363861 | ||
| Ly-49-independent natural killer (NK) cell specificity revealed by NK cell clones derived from p53-deficient mice | Q36364791 | ||
| Requirement for natural killer cell-produced interferon gamma in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration | Q36365733 | ||
| Heterogeneous phenotypes of expression of the NKB1 natural killer cell class I receptor among individuals of different human histocompatibility leukocyte antigens types appear genetically regulated, but not linked to major histocompatibililty comple | Q36366358 | ||
| Resistance of CD7-deficient mice to lipopolysaccharide-induced shock syndromes | Q36368123 | ||
| What goes up must come down: the emerging spectrum of inhibitory receptors | Q36380962 | ||
| Early murine cytomegalovirus (MCMV) infection induces liver natural killer (NK) cell inflammation and protection through macrophage inflammatory protein 1alpha (MIP-1alpha)-dependent pathways | Q36381040 | ||
| Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis | Q36400442 | ||
| Expression of CD3-zeta on T-cells in primary cervical carcinoma and in metastasis-positive and -negative pelvic lymph nodes | Q36617463 | ||
| A potential role for interleukin-15 in the regulation of human natural killer cell survival | Q37364381 | ||
| Contribution of CR3, CD11b/CD18 to cytolysis by human NK cells | Q37608215 | ||
| Involvement of transcription factors TCF-1 and GATA-3 in the initiation of the earliest step of T cell development in the thymus | Q38353243 | ||
| The neural cell adhesion molecule (NCAM) as a regulator of cell-cell interactions | Q39634900 | ||
| Natural killer cell receptors: the offs and ons of NK cell recognition. | Q40480272 | ||
| Chronic myelogenous leukemia: in search of the benign hematopoietic stem cell | Q40620489 | ||
| Clonal acquisition of the Ly49A NK cell receptor is dependent on the trans-acting factor TCF-1. | Q40919610 | ||
| Evaluation of natural killer cell expansion and activation in vivo with daily subcutaneous low-dose interleukin-2 plus periodic intermediate-dose pulsing. | Q41005627 | ||
| Interferon gamma production by natural killer (NK) cells and NK1.1+ T cells upon NKR-P1 cross-linking | Q41202614 | ||
| Natural Killer (NK) Activity in Human Responders and Nonresponders to Stimulation by Anti-CD16 Antibodies | Q41330870 | ||
| Killer cell inhibitory receptors: diversity, specificity, and function | Q41373720 | ||
| Arousal and inhibition of human NK cells | Q41373731 | ||
| Signal transduction during natural killer cell activation: inside the mind of a killer | Q41518907 | ||
| Signaling through the LFA-1 leucocyte integrin actively regulates intercellular adhesion and tumor necrosis factor-alpha production in natural killer cells. | Q41536684 | ||
| The killer cell inhibitory receptor genomic region on human chromosome 19q13.4. | Q41542863 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 405-419 | |
| P577 | publication date | 2002-01-01 | |
| P1433 | published in | Cancer Investigation | Q325953 |
| P1476 | title | Biology of natural killer cells in cancer and infection | |
| P478 | volume | 20 |
| Q21284457 | Antiinflammatory and immunomodulating properties of fungal metabolites |
| Q36557562 | Detecting the unusual: natural killer cells |
| Q27344690 | Dynamic contrast enhanced MRI detects early response to adoptive NK cellular immunotherapy targeting the NG2 proteoglycan in a rat model of glioblastoma |
| Q43761885 | Good manufacturing practices production of natural killer cells for immunotherapy: a six-year single-institution experience |
| Q58572823 | High expression of GALNT7 promotes invasion and proliferation of glioma cells |
| Q36423437 | Hydrodynamic delivery of human IL-15 cDNA increases murine natural killer cell recovery after syngeneic bone marrow transplantation |
| Q39522922 | IQGAP1 involvement in MTOC and granule polarization in NK-cell cytotoxicity |
| Q37807988 | Immunoregulatory actions of polysaccharides from Chinese herbal medicine |
| Q60920839 | Innate Immunity Cells and the Neurovascular Unit |
| Q33703214 | Licensing delineates helper and effector NK cell subsets during viral infection |
| Q43609980 | Lung natural killer cells in mice: phenotype and response to respiratory infection |
| Q35127969 | Mouse Ly49G2+ NK cells dominate early responses during both immune reconstitution and activation independently of MHC |
| Q35776463 | Mouse NK cell-mediated rejection of bone marrow allografts exhibits patterns consistent with Ly49 subset licensing |
| Q36820198 | Murine natural killer cell licensing and regulation by T regulatory cells in viral responses |
| Q33351527 | Myelodysplastic syndromes: the role of the immune system in pathogenesis |
| Q35866235 | Natural killer cells and exercise training in the elderly: a review |
| Q35826605 | Natural killer cells are involved in acute lung immune injury caused by respiratory syncytial virus infection |
| Q37209082 | Negative effect of KIR alloreactivity in recipients of umbilical cord blood transplant depends on transplantation conditioning intensity |
| Q35641142 | Opposing roles of NF-kappaB family members in the regulation of NK cell proliferation and production of IFN-gamma |
| Q36675436 | Potential therapeutic role of natural killer cells in cancer |
| Q34186486 | Production Assistance for Cellular Therapies (PACT): four-year experience from the United States National Heart, Lung, and Blood Institute (NHLBI) contract research program in cell and tissue therapies |
| Q33734981 | Synergistic potentiation of D-fraction with vitamin C as possible alternative approach for cancer therapy |
| Q37299271 | Targeting glioblastoma with NK cells and mAb against NG2/CSPG4 prolongs animal survival |
| Q35743681 | The PD-1/B7-H1 pathway modulates the natural killer cells versus mouse glioma stem cells |
| Q35158955 | The graft versus leukemia response after allogeneic hematopoietic stem cell transplantation. |
| Q33715602 | The mature activating natural killer cell immunologic synapse is formed in distinct stages |
| Q47268388 | The role of IL-18 in the modulation of matrix metalloproteinases and migration of human natural killer (NK) cells |
| Q24793617 | Tissue detection of natural killer cells in colorectal adenocarcinoma |
| Q64106116 | Viral Infection of Human Natural Killer Cells |
Search more.